Daniel J Rohrbach1, Daniel Muffoletto2, Jonathan Huihui1, Rolf Saager3, Kenneth Keymel1, Anne Paquette4, Janet Morgan4, Nathalie Zeitouni4, Ulas Sunar5. 1. Department of Cell Stress Biology and PDT Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263. 2. Department of Electrical Engineering, University at Buffalo, Buffalo, NY. 3. Beckman Laser Institute, Irvine, CA. 4. Department of Dermatology, Roswell Park Cancer Institute, Buffalo, NY. 5. Department of Cell Stress Biology and PDT Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263. Electronic address: ulas.sunar@roswellpark.org.
Abstract
RATIONALE AND OBJECTIVES: The treatment of nonmelanoma skin cancer (NMSC) is usually by surgical excision or Mohs micrographic surgery and alternatively may include photodynamic therapy (PDT). To guide surgery and to optimize PDT, information about the tumor structure, optical parameters, and vasculature is desired. MATERIALS AND METHODS: Spatial frequency domain imaging (SFDI) can map optical absorption, scattering, and fluorescence parameters that can enhance tumor contrast and quantify light and photosensitizer dose. High frequency ultrasound (HFUS) imaging can provide high-resolution tumor structure and depth, which is useful for both surgery and PDT planning. RESULTS: Here, we present preliminary results from our recently developed clinical instrument for patients with NMSC. We quantified optical absorption and scattering, blood oxygen saturation (StO2), and total hemoglobin concentration (THC) with SFDI and lesion thickness with ultrasound. These results were compared to histological thickness of excised tumor sections. CONCLUSIONS: SFDI quantified optical parameters with high precision, and multiwavelength analysis enabled 2D mappings of tissue StO2 and THC. HFUS quantified tumor thickness that correlated well with histology. The results demonstrate the feasibility of the instrument for noninvasive mapping of optical, physiological, and ultrasound contrasts in human skin tumors for surgery guidance and therapy planning.
RATIONALE AND OBJECTIVES: The treatment of nonmelanoma skin cancer (NMSC) is usually by surgical excision or Mohs micrographic surgery and alternatively may include photodynamic therapy (PDT). To guide surgery and to optimize PDT, information about the tumor structure, optical parameters, and vasculature is desired. MATERIALS AND METHODS: Spatial frequency domain imaging (SFDI) can map optical absorption, scattering, and fluorescence parameters that can enhance tumor contrast and quantify light and photosensitizer dose. High frequency ultrasound (HFUS) imaging can provide high-resolution tumor structure and depth, which is useful for both surgery and PDT planning. RESULTS: Here, we present preliminary results from our recently developed clinical instrument for patients with NMSC. We quantified optical absorption and scattering, blood oxygen saturation (StO2), and total hemoglobin concentration (THC) with SFDI and lesion thickness with ultrasound. These results were compared to histological thickness of excised tumor sections. CONCLUSIONS: SFDI quantified optical parameters with high precision, and multiwavelength analysis enabled 2D mappings of tissue StO2 and THC. HFUS quantified tumor thickness that correlated well with histology. The results demonstrate the feasibility of the instrument for noninvasive mapping of optical, physiological, and ultrasound contrasts in humanskin tumors for surgery guidance and therapy planning.
Authors: Xiaodong Zhou; Brian W Pogue; Bin Chen; Eugene Demidenko; Rohan Joshi; Jack Hoopes; Tayyaba Hasan Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-15 Impact factor: 7.038
Authors: J T van den Akker; H S de Bruijn; G M Beijersbergen van Henegouwen; W M Star; H J Sterenborg Journal: Photochem Photobiol Date: 2000-09 Impact factor: 3.421
Authors: Lesley E Rhodes; Menno A de Rie; Ragna Leifsdottir; Raymond C Yu; Ingeborg Bachmann; Victoria Goulden; Gavin A E Wong; Marie-Aleth Richard; Alex Anstey; Peter Wolf Journal: Arch Dermatol Date: 2007-09
Authors: Lesley E Rhodes; Menno de Rie; Ylva Enström; Richard Groves; Tore Morken; Victoria Goulden; Gavin A E Wong; Jean-Jacques Grob; Sandeep Varma; Peter Wolf Journal: Arch Dermatol Date: 2004-01
Authors: Barbara W Henderson; Sandra O Gollnick; John W Snyder; Theresa M Busch; Philaretos C Kousis; Richard T Cheney; Janet Morgan Journal: Cancer Res Date: 2004-03-15 Impact factor: 12.701
Authors: Chien Poon; Ulas Sunar; Daniel J Rohrbach; Smita Krishnamurthy; Thomas Olsen; Michael Kent; Nathan M Weir; Richard Simman; Jeffrey B Travers Journal: Toxicol In Vitro Date: 2018-06-01 Impact factor: 3.500